Pharma manufacturing news in brief
May 10, 2010Manufacturing and Production American Peptide, DSM Biologics, Dutch CMO SynCo Bio Partners, KV Pharmaceutical, Merck & Co, manufacturing
This week’s round-up of pharmaceutical manufacturing news includes facility updates from KV Pharmaceutical, DSM Biologics, Merck & Co and American …
In search of a real solution to the counterfeit problem
May 10, 2010Manufacturing and Production Plavix, counterfeits, supply chain
For a great deal of the last decade, warnings from the pharmaceutical industry about the growing threat of counterfeit medicines …
Boehringer signs antibody myeloma R&D deal
May 10, 2010Research and Development Boehringer, Cancer, Micromet, myeloma
Boehringer Ingelheim and US biotech company Micromet are to research and develop a new BiTE antibody to treat multiple myeloma. …
Lundbeck delivers strong results and builds on pipeline
May 7, 20102010 financials, Azilect, Lundbeck
Denmark-based Lundbeck has seen a large jump in revenue for the first quarter thanks to steady growth from its lead …
European court backs prescribing incentives
May 7, 2010Sales and Marketing prescribing incentives
Payments to persuade UK doctors to prescribe generics have been backed by a European court, thwarting pharma attempts to have …
Digital Pharma: Novartis rebuked for “false and misleading” websites
May 7, 2010Medical Communications disease awareness campaigns
The FDA has issued Novartis with a stern warning over two websites it sponsors, saying it considers gistalliance.com and cmlalliance.com …
Mixed fortunes for major CROs in Q1
May 7, 2010Research and Development CRO, Covance, ICON, PPD, Parexel, contact research, contract research, contract research organisation
Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …
Encouraging data for ThromboGenics and BioInvent product
May 7, 2010BioInvent, Lovenox, ThromboGenics, VTE
An antibody-based drug to prevent blood clots after orthopaedic surgery has shown promising results in phase II. TB-402 is a …
Congress to probe McNeil’s GMP violations
May 7, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The US Food and Drug Administration may take additional regulatory action against Johnson & Johnson subsidiary McNeil Consumer Healthcare over …
EMA appoints Alexis Nolte head of quality
May 7, 2010Manufacturing and Production EMA, appointment, manufacturing and production
The European Medicines Agency has appointed Alexis Nolte to head up its Quality of Medicines Sector. He was previously principal …
New audiences, new marketing tools
May 6, 2010Sales and Marketing brand, branding, marketing, marketing ideas
Pharmaceutical industry marketers have for many years focused on turning good products into great brands, developing strong core propositions which …
Congress criticises FDA over contaminated heparin case
May 6, 2010Manufacturing and Production heparin, manufacturing compliance
The US Food and Drug Administration’s follow-up of the contaminated heparin scandal which surfaced in 2008 has been inadequate, according …
AZ signs tuberculosis drug discovery deal
May 6, 2010Research and Development AstraZeneca, India, TB, tuberculosis
AstraZeneca and the Global Alliance for TB Drug Development are to collaborate on the discovery and development of drugs to treat tuberculosis.The two …
Abbott’s Mark Kontny joins Patheon
May 6, 2010Manufacturing and Production Patheon, appointment, manufacturing and production
Patheon has appointed Dr Mark Kontny president of global pharmaceutical development services and chief scientific officer. He joins the contract …
Pfizer and Merck post modest results
May 6, 2010Sales and Marketing 2010 financials, Merck, Pfizer
The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine. Both …
Greece’s crisis could hit European prices
May 6, 2010Sales and Marketing Greece, industry, parallel trade, prices
GlaxoSmithKline’s chief executive Andrew Witty has warned that the economic crisis in Greece could have a knock-on effect across Europe, …
Sanofi signs Indian pain drug development deal
May 5, 2010Research and Development Glenmark, Sanofi-Aventis, chronic pain, pain therapeutics
Sanofi-Aventis has signed an agreement with Indian firm Glenmark Pharmaceuticals to develop novel agents for the treatment of chronic pain. …
Collaborative cancer drug project targets research efficiency
May 5, 2010Research and Development Animal testing, Animal tests, Cancer, biomarkers, clinical drug development
A new pharma-academia project being managed by the University of Dundee is setting its sights on improving the effectiveness of …
Digital Pharma: Online medical information influences treatment
May 5, 2010Medical Communications, Sales and Marketing Datapharm, digital patients, patient information
More than half of health searches in the UK result in treatment or management changes, according to new research by …
Virgo expands med ed team
May 5, 2010Medical Communications Virgo, appointment, medical communications
Virgo Health has expanded its medical education offering, appointing Katherine Mantell and Adam Pittard. Katherine joins the agency as editorial …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
